Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure

New England Journal of Medicine

Volumn 336, Issue 9, 1997, Pages 597-604

  Ehrenkranz, Richard A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHEMOGLOBIN; NITRIC OXIDE;

ARTERIAL OXYGEN TENSION; ARTICLE; BRAIN INFARCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; ENCEPHALOMALACIA; EXTRACORPOREAL OXYGENATION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPOXIA; INHALATIONAL DRUG ADMINISTRATION; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; MECONIUM ASPIRATION; MORTALITY; MULTICENTER STUDY; NEWBORN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY FAILURE; SEIZURE; SEPSIS; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; MECONIUM ASPIRATION SYNDROME; METHEMOGLOBINEMIA; NITRIC OXIDE; OXYGEN; OXYGEN INHALATION THERAPY; PERSISTENT FETAL CIRCULATION SYNDROME; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RESPIRATORY INSUFFICIENCY; TREATMENT OUTCOME;

EID: 0031052369     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199702273360901     Document Type: Article

References (30)

1. Gersony WM. Neonatal pulmonary hypertension: pathophysiology, classification, and etiology. Clin Perinatol 1984;11:517-24.
2. Graves ED III, Redmond CR, Arensman RM. Persistent pulmonary hypertension in the neonate. Chest 1988;93:638-41.
3. Fox WW, Duara S. Persistent pulmonary hypertension in the neonate: diagnosis and management. J Pediatr 1983;103:505-14.
4. Drummond WH, Gregory GA, Heymann MA, Phibbs RA. The independent effects of hyperventilation, tolazoline, and dopamine on infants with persistent pulmonary hypertension. J Pediatr 1981;98:603-11.
5. Walsh-Sukys MC, Cornell DJ, Houston LN, Keszler M, Kanto WP Jr. Treatment of persistent pulmonary hypertension of the newborn without hyperventilation: an assessment of diffusion of innovation. Pediatrics 1994; 94:303-6.
6. Wung JT, James LS, Kilchevsky E, James E. Management of infants with severe respiratory failure and persistence of the fetal circulation, without hyperventilation. Pediatrics 1985;76:488-94.
7. Kulik TJ, Lock JE. Pulmonary vasodilator therapy in persistent pulmonary hypertension of the newborn. Clin Perinatol 1984;11:693-701.
8. Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 1989;65:1-21.
9. Idem. Endothelium-derived nitric oxide: actions and properties. FASEB J 1989;3:31-6.
10. Archer SL, Rist K, Nelson DP, DeMaster EG, Cowan N, Weir EK. Comparison of the hemodynamic effects of nitric oxide and endothelium-dependent vasodilators in intact lungs. J Appl Physiol 1990;68:735-47.
11. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 1989;3:2007-18.
12. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327:524-6.
13. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 1987;84:9265-9.
14. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide - a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991;83:2038-47. [Erratum, Circulation 1991;84:2212.]
15. Fratacci MD, Frostell CG, Chen TY, Wain JC Jr, Robinson DR, Zapol WM. Inhaled nitric oxide - a selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. Anesthesiology 1991;75:990-9.
16. Roberts JD Jr, Chen TY, Kawai N, et al. Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb. Circ Res 1993;72:246-54.
17. Kinsella JP, Neish SR, Shaffer E, Abman SH. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340:819-20.
18. Roberts JD, Polaner DM, Lang P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340:818-9.
19. Finer NN, Etches PC, Kamstra B, Tierney AJ, Peliowski A, Ryan CA. Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response. J Pediatr 1994;124:302-8.
20. Rossaint R, Falke KJ, López F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993;328:399-405.
21. Pison U, Lopez FA, Heidelmeyer CF, Rossaint R, Falke KJ. Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction without impairing gas exchange. J Appl Physiol 1993;74:1287-92.
22. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92:529-34.
23. Gart JJ. Approximate tests and interval estimation of the common relative risk in the combination of 2 × 2 tables. Biometrika 1985;72:673-7.
24. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983;70:659-63.
25. Radomski MW, Moncada S. Regulation of vascular homeostasis by nitric oxide. Thromb Haemost 1993;70:36-41.
26. Högman M, Frostell C, Arnberg H, Hedenstierna G. Bleeding time prolongation and NO inhalation. Lancet 1993;341:1664-5.
27. Högman M, Frostell C, Arnberg H, Sandhagen B, Hedenstierna G. Prolonged bleeding time during nitric oxide inhalation in the rabbit. Acta Physiol Scand 1994;151:125-9.
28. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxides. Proc Natl Acad Sci U S A 1990;87:1620-4.
29. Lafon-Cazal M, Culcasi M, Gaven F, Pietri S, Bockaert J. Nitric oxide, superoxide and peroxynitrite: putative mediators of NMDA-induced death in cerebellar granule cells. Neuropharmacology 1993;32:1259-66.
30. Bartlett RH, Gazzaniga AB, Toomasian J, et al. Extracorporeal membrane oxygenation (ECMO) in neonatal respiratory failure: 100 cases. Ann Surg 1986;204:236-45. [Erratum, Ann Surg 1987;205:11A.]